How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant
L Alinari, KA Blum - Blood, The Journal of the American Society …, 2016 - ashpublications.org
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
[HTML][HTML] How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant
L Alinari, KA Blum - Blood, 2016 - Elsevier
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant.
L Alinari, KA Blum - Blood, 2015 - europepmc.org
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
How i treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant
L Alinari, KA Blum - Blood, 2016 - ohiostate.elsevierpure.com
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant
L Alinari, KA Blum - Blood, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Despite the success of standard front-line
chemotherapy for classical Hodgkin lymphoma (cHL), a subset of these patients, particularly …
chemotherapy for classical Hodgkin lymphoma (cHL), a subset of these patients, particularly …
How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant
L Alinari, KA Blum - Blood, 2016 - pubmed.ncbi.nlm.nih.gov
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …
(cHL), a subset of these patients, particularly those with poor prognostic factors at diagnosis …